Tomoo Furumoto Selected Research

Tomoo Furumoto Research Topics

Disease

10	Hypertension (High Blood Pressure) 12/2018 - 05/2002
8	Atherosclerosis 10/2017 - 03/2002
6	Coronary Artery Disease (Coronary Atherosclerosis) 11/2023 - 06/2007
5	Type 2 Diabetes Mellitus (MODY) 11/2023 - 03/2005
4	Inflammation (Inflammations) 06/2014 - 05/2002
3	Heart Failure 02/2018 - 02/2006
3	Diabetes Mellitus 11/2017 - 03/2010
3	Insulin Resistance 08/2008 - 08/2004
3	Hepatocellular Carcinoma (Hepatoma) 08/2008 - 09/2003
2	Hyperglycemia 01/2016 - 01/2015
2	Obesity 12/2013 - 08/2004
2	Thrombosis (Thrombus) 10/2006 - 06/2003
2	Acute-Phase Reaction 05/2005 - 09/2003
2	Fibrosis (Cirrhosis) 03/2005 - 08/2004
1	Hypoxia (Hypoxemia) 12/2013
1	Carotid Artery Diseases 01/2012
1	Hyperuricemia 09/2011
1	Death (Near-Death Experience) 09/2011
1	Cardiovascular Diseases (Cardiovascular Disease) 02/2011
1	Left Ventricular Dysfunction 03/2010
1	Myocardial Infarction 08/2008
1	Essential Hypertension 09/2007
1	Diastolic Heart Failure 03/2005

Drug/Important Bio-Agent (IBA)

9	Plasminogen Activator Inhibitor 1IBA 12/2013 - 09/2003
5	Plasminogen InactivatorsIBA 03/2007 - 04/2004
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2023 - 09/2003
3	Interleukin-6 (Interleukin 6)IBA 06/2007 - 09/2003
2	Triglycerides (Triacylglycerol)IBA 11/2023 - 03/2007
2	LDL CholesterolIBA 11/2023 - 03/2007
2	LipidsIBA 01/2022 - 10/2017
2	Biomarkers (Surrogate Marker)IBA 11/2017 - 01/2012
2	Metformin (Glucophage)FDA LinkGeneric 10/2017 - 01/2016
2	Dipeptidyl-Peptidase IV InhibitorsIBA 10/2017 - 01/2016
2	SphingosineIBA 06/2014 - 12/2013
2	Messenger RNA (mRNA)IBA 12/2013 - 03/2005
2	Angiotensin Receptor AntagonistsIBA 03/2010 - 09/2007
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 03/2010 - 08/2004
2	Insulin (Novolin)FDA Link 08/2008 - 06/2003
2	olmesartanIBA 09/2007 - 08/2004
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2007 - 05/2002
2	Plasminogen Activators (Plasminogen Activator)IBA 09/2003 - 06/2003
2	InterleukinsIBA 09/2003 - 05/2002
1	oxidized low density lipoproteinIBA 01/2022
1	Uric Acid (Urate)IBA 12/2018
1	VildagliptinIBA 10/2017
1	AdipokinesIBA 10/2017
1	glimepiride (Amarel)FDA LinkGeneric 01/2016
1	Glucose (Dextrose)FDA LinkGeneric 01/2016
1	IncretinsIBA 01/2016
1	Sitagliptin Phosphate (Januvia)FDA Link 01/2016
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2015
1	Liraglutide FDA Link 01/2015
1	Phosphates (Orthophosphate)IBA 06/2014
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 12/2013
1	LyasesIBA 12/2013
1	Conditioned Culture MediaIBA 12/2013
1	Indicators and Reagents (Reagents)IBA 02/2011
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 03/2010
1	Amlodipine (Norvasc)FDA LinkGeneric 09/2007
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 09/2007
1	HDL CholesterolIBA 03/2007
1	HDL LipoproteinsIBA 03/2007
1	Angiotensin II Type 1 Receptor BlockersIBA 02/2007
1	Losartan (Cozaar)FDA LinkGeneric 02/2007
1	CarbohydratesIBA 10/2006
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2006
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 10/2006
1	Brain Natriuretic Peptide (Natrecor)FDA Link 02/2006
1	Deoxyribonucleases (DNase)FDA Link 05/2005
1	LuciferasesIBA 05/2005
1	mevastatin (CS 500)IBA 05/2005
1	Deoxyribonuclease I (Nickase)IBA 05/2005
1	Insulin Receptor Substrate ProteinsIBA 03/2005
1	temocapril hydrochloride (temocapril)IBA 08/2004
1	Phosphotransferases (Kinase)IBA 08/2004
1	Hydroxyproline (4 Hydroxyproline)IBA 08/2004
1	Transforming Growth Factors (Transforming Growth Factor)IBA 08/2004
1	CollagenIBA 08/2004
1	Transforming Growth Factor beta (TGF-beta)IBA 08/2004
1	Collagen Type I (Type I Collagen)IBA 08/2004
1	Angiotensin IIIBA 08/2004
1	CytokinesIBA 09/2003
1	Tissue Plasminogen Activator (Alteplase)FDA Link 05/2002
1	Apolipoproteins E (ApoE)IBA 03/2002
1	ApolipoproteinsIBA 03/2002

Therapy/Procedure

6	Therapeutics 01/2019 - 12/2013
1	Patient Readmission 09/2011